These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23988464)

  • 1. Ascertaining cause of death among men in the prostate cancer intervention versus observation trial.
    Barry MJ; Andriole GL; Culkin DJ; Fox SH; Jones KM; Carlyle MH; Wilt TJ
    Clin Trials; 2013; 10(6):907-14. PubMed ID: 23988464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
    Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High accuracy of Swedish death certificates in men participating in screening for prostate cancer: a comparative study of official death certificates with a cause of death committee using a standardized algorithm.
    Godtman R; Holmberg E; Stranne J; Hugosson J
    Scand J Urol Nephrol; 2011 Sep; 45(4):226-32. PubMed ID: 21463227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer.
    Holmberg L; Bill-Axelson A; Helgesen F; Salo JO; Folmerz P; Häggman M; Andersson SO; Spångberg A; Busch C; Nordling S; Palmgren J; Adami HO; Johansson JE; Norlén BJ;
    N Engl J Med; 2002 Sep; 347(11):781-9. PubMed ID: 12226148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of cause of death determination in men previously diagnosed with prostate cancer who died in 1985 or 1995.
    Albertsen PC; Walters S; Hanley JA
    J Urol; 2000 Feb; 163(2):519-23. PubMed ID: 10647669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability of death certificates in prostate cancer patients.
    Fall K; Strömberg F; Rosell J; Andrèn O; Varenhorst E;
    Scand J Urol Nephrol; 2008; 42(4):352-7. PubMed ID: 18609293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prostate Cancer Intervention Versus Observation Trial (PIVOT).
    Wilt TJ; Brawer MK
    Oncology (Williston Park); 1997 Aug; 11(8):1133-9; discussion 1139-40, 1143. PubMed ID: 9268976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radical prostatectomy versus watchful waiting in early prostate cancer.
    Bill-Axelson A; Holmberg L; Ruutu M; Häggman M; Andersson SO; Bratell S; Spångberg A; Busch C; Nordling S; Garmo H; Palmgren J; Adami HO; Norlén BJ; Johansson JE;
    N Engl J Med; 2005 May; 352(19):1977-84. PubMed ID: 15888698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the source of death information affect cancer screening efficacy results? A study of the use of mortality review versus death certificates in four randomized trials.
    Doria-Rose VP; Marcus PM; Miller AB; Bergstralh EJ; Mandel JS; Tockman MS; Prorok PC
    Clin Trials; 2010 Feb; 7(1):69-77. PubMed ID: 20156958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
    Johansson E; Bill-Axelson A; Holmberg L; Onelöv E; Johansson JE; Steineck G;
    Eur Urol; 2009 Feb; 55(2):422-30. PubMed ID: 18783877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial.
    Bill-Axelson A; Garmo H; Holmberg L; Johansson JE; Adami HO; Steineck G; Johansson E; Rider JR
    Eur Urol; 2013 Dec; 64(6):920-8. PubMed ID: 23465517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial management of prostate-specific antigen-detected, low-risk prostate cancer and the risk of death from prostate cancer.
    Aizer AA; Chen MH; Hattangadi J; D'Amico AV
    BJU Int; 2014 Jan; 113(1):43-50. PubMed ID: 23473327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prostate Cancer Intervention Versus Observation Trial: a randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer.
    Wilt TJ; Brawer MK
    J Urol; 1994 Nov; 152(5 Pt 2):1910-4. PubMed ID: 7523736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of screening on radical prostatectomy efficacy: the prostate cancer intervention versus observation trial.
    Xia J; Gulati R; Au M; Gore JL; Lin DW; Etzioni R
    J Natl Cancer Inst; 2013 Apr; 105(8):546-50. PubMed ID: 23411592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate Intervention Versus Observation Trial (PIVOT): a randomized trial comparing radical prostatectomy with palliative expectant management for treatment of clinically localized prostate cancer. PIVOT Planning Committee.
    Moon TD; Brawer MK; Wilt TJ
    J Natl Cancer Inst Monogr; 1995; (19):69-71. PubMed ID: 7577210
    [No Abstract]   [Full Text] [Related]  

  • 18. Managing localized prostate cancer by radical prostatectomy or watchful waiting: Cost analysis of a randomized trial (SPCG-4).
    Andersson SO; Andrén O; Lyth J; Stark JR; Henriksson M; Adami HO; Carlsson P; Johansson JE
    Scand J Urol Nephrol; 2011 Apr; 45(3):177-83. PubMed ID: 21265595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Only <10% of Patients Selected for Radical Prostatectomy Reach the Competing Mortality Rate of the Prostate Cancer Intervention Versus Observation Trial (PIVOT).
    Froehner M; Koch R; Hübler M; Renner T; Borkowetz A; Zastrow S; Wirth MP
    Eur Urol Focus; 2019 May; 5(3):361-364. PubMed ID: 29426695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-specific and other-cause mortality after radical prostatectomy versus observation in patients with prostate cancer: competing-risks analysis of a large North American population-based cohort.
    Abdollah F; Sun M; Schmitges J; Tian Z; Jeldres C; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
    Eur Urol; 2011 Nov; 60(5):920-30. PubMed ID: 21741762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.